Detalhe da pesquisa
1.
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Lancet Oncol
; 22(12): 1669-1680, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34741822
2.
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
JAMA Oncol
; 8(1): 114-122, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817562
3.
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective.
Ther Adv Med Oncol
; 13: 17588359211042224, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34497669
4.
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
J Immunother Cancer
; 9(3)2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753569
5.
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.
Cancers (Basel)
; 12(7)2020 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32650523
6.
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
Cancer Discov
; 2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737082